GLP-1 Medications for Weight Loss: A 42-Year Fitness Professional’s Honest Take

GLP-1 medications for weight loss are everywhere right now. Some people call them a miracle, others call them dangerous.

Instead of hype or fear-mongering, let’s get the perspective of a 42-fitness professional and what the science says, what she’s seen with real clients, and what concerns fitness professionals need to understand about GLP-1 medications.

You’ll hear both sides of the conversation: the real metabolic benefits and the real risks, especially when it comes to muscle loss, nutrition, and long-term metabolic health.

If you’ve considered GLP-1 medications for weight loss, are currently taking them, or work with clients who are, this episode will help you make a more informed decision.

What GLP-1 Medications Were Originally Designed For

• GLP-1 receptor agonists were originally created for diabetes management.
• Only in the past 3–5 years have they become widely used for weight loss.

As a fitness professional working primarily with women in midlife and beyond, my lens is simple:

• Is it improving health?
• Is it preserving muscle?
• Is it sustainable?
• Is it aligned with long-term vitality?

Today I’m breaking this into two clear sections:

• Part I: What I Like
• Part II: What Concerns Me

And I’ll back it with science.

What Every Woman Over 40 Should Know About GLP-1 Medications for Weight Loss

PART I: WHAT I LIKE

1. Reduction in Inflammation
   • • Chronic inflammation contributes to:
       • • cardiovascular risk
         • insulin resistance
         • joint pain
         • fatigue
     • 68-week STEP 1 trial (New England Journal of Medicine. 2021, PMID: 33567185) shows GLP-1 medications can lower C-reactive protein (CRP), a marker of systemic inflammation.
     • Lower inflammation may improve metabolic health and reduce weight loss resistance.
       
       
2. Cardiovascular Risk Reduction
   • • A SELECT trial (New England Journal of Medicine. 2023, PMID: 37952131) followed over 17,000 adults with cardiovascular disease risk. Results showed major improvements — about a 20% reduction in major cardiovascular events among those using semaglutide.
     • This benefit extends beyond weight loss alone.
       
       
3. Improved Insulin Sensitivity
   • • The STEP trials also demonstrated:
       • • reduced HbA1c
         • improved fasting glucose
         • improved markers of insulin resistance
     • For postmenopausal women, insulin resistance often increases due to estrogen decline.
     • When blood sugar regulation improves, energy improves.
       
       
4. Reduction in “Food Noise” 
   • • In appetite-focused studies (Diabetes, Obesity and Metabolism. 2017, PMID: 28266779), participants reported::
       • • lower hunger signals
         • increase satiety
         • reduce cravings for high-fat foods
     • Some women who felt out of control around food finally experience:
       • • quiet in their mind
         • space to make decisions
         • 
           motivation to start strength training

            

PART II: WHAT CONCERNS ME

1. Lean Mass Loss
   • • One of the biggest concerns in weight loss with GLP-1 medications.
     • The STEP 1 trial suggests 39–40% of weight loss may come from lean mass.
     • Losing muscle can negatively affect:
       • • metabolic rate
         • strength
         • bone density
     • Women over 50 are already losing muscle due to sarcopenia, making this risk even greater.
     • If resistance training and protein intake are not prioritized, the metabolic benefit erodes.